Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-265.50M
↓ 116% below average
Average (9y)
$-122.90M
Historical baseline
Range
High:$-10.57M
Low:$-265.50M
CAGR
+43.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-265.50M | -44.0% |
| 2023 | $-184.36M | -2.9% |
| 2022 | $-179.16M | -5.3% |
| 2021 | $-170.06M | -24.5% |
| 2020 | $-136.57M | +6.5% |
| 2019 | $-146.00M | -86.2% |
| 2018 | $-78.42M | -141.9% |
| 2017 | $-32.41M | -25.1% |
| 2016 | $-25.91M | -145.0% |
| 2015 | $-10.57M | - |